ALDH7A1 and glioblastoma: To assess the pharmacological inhibition of PDEs as a potential glioblastoma treatment, we examined the effects of 28 selected PDE inhibitors, covering the entire range of PDE isoforms, on cell proliferation and cAMP and cGMP levels in the human glioblastoma cell lines U87MG, A172 and T98G.